Pulmonary multi-drug resistant tuberculosis: a radiological review

doi:10.19871/j.cnki.xfcrbzz.2021.01.015

Abstract

Abstract: Drug-resistant tuberculosis is a respiratory infectious disease caused by drug-resistant Mycobacterium tuberculosis, which seriously threatens human health. The disease is poorly treated, especially multidrug-resistant tuberculosis (MDR-TB).Therefore, timely detection of MDR-TB can enable patients to be better managed and treated.Based on published literature, this article searches the PubMed database in October 2019. The search keyword combination is "(multidrug-resistant tuberculosis) AND (CT or radiograph or imaging or X-ray or computed tomography)", while searching Wanfang Medical database, the search keyword combination is "(multidrug-resistant tuberculosis) and (CT or radiology or imaging or X-ray)" to analyze and summarize the progress of MDR-TB in imaging research.The published literature shows that MDR-TB patients have no definite chest imaging diagnosis basis. When the chest X-ray and CT, the patient appears lung cavity, especially the larger the cavity or the thicker the cavity wall, the more prompt It is the possibility of MDR-TB, and the imaging doctor should doubt the possibility of MDR-TB when there is the appearance of damaged lung imaging.At the same time, the analysis results show that CT is the main imaging method, and X-rays have certain limitations. Positron Emission Tomography-Computed Tomography (PET-CT) is currently only applicable to assess MDR-TB treatment. The result description is not concise, you can refer to how other similar articles are described. Using artificial intelligence (AI) technology for MDR-TB auxiliary diagnosis will become a new key research direction in the future.

Key words: Tuberculosis, Multidrug-resistant tuberculosis, Computed tomography

Ma Luyao, Zheng Qiuting, Lu Puxuan, Li Hongjun, Fleming YM Lure, Yin Xiaoping, Guo Lin. Pulmonary multi-drug resistant tuberculosis: a radiological review[J]. Electronic Journal of Emerging Infectious Diseases, 2021, 6(1): 65-72.

References

[1] BARBERIS I, BRAGAZZI NL, GALLUZZO L, et al.The history of tuberculosis: from the first historical records to the isolation of Koch's bacillus[J]. J Prev Med Hyg, 2017, 58(1): E9.
[2] WORLD HEALTH ORGANIZATION. Global tuberculosis report2018 [EB/OL]. [2018-09-18] . https://www.who.int/tb/Publications/global_report/en/.
[3] WRIGHT A, ZIGNOL M, VAN DA, et al.Epidemiology of antituberculosis drug resistance 2002-07: an up-dated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance[J]. Lancet, 2009, 373(9678): 1861-1873.
[4] ZIGNOL M, GEMERT W, FALZON D, et al.Surveillance of anti-tuberculosis drug resistance in the world: ani.Updated analysis, 2007-2010[J]. BullWorld Health Organ, 2012, 90(2): 111-119.
[5] CENTERS FOR DISEASE CONTROL AND PREVENTION(CDC). Emergence of Mycobacterium tuberculosis with extensve resistance to second-line drugs--worldwide, 2000-2004[J]. MMWR, 2006, 55(11): 301.
[6] WORLD HEALTH ORGANIZATION.Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis[EB/OL]. https://apps.who.int/iris/rest/bitstreams/1327986/retrieve.
[7] 余卫业, 谭卫国, 陆普选. 耐药肺结核的分类, 分型及影像学表现[J/CD]. 新发传染病电子杂志, 2019, 4(1): 42-47.
[8] AMERICAN THORACIC SOCIETY.Diagnostic standards and classification of tuberculosis in adults and children[J]. Am J Respir Crit Care Med, 2000, 161(4): 1376-1395.
[9] GOO JM, IM JG.CT of tuberculosis and nontuberculous mycobacterial infections[J]. Radiol Clin, 2002, 40(1): 73-87.
[10] GANDHI NR, MOLL A, STURM AW, et al.Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa[J]. Lancet, 2006, 368(9547): 1575-1580.
[11] KIM HR, HWANG SS, KIM HJ, et al.Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis[J]. Clin Infect Dis, 2007, 45(10): 1290-1295.
[12] MIGLIORI GB, LANGE C, GIRARDI E, et al.Extensively drug-resistant tuberculosis is worse than multidrug-resistant tuberculosis: different methodology and settings, same results[J]. Clin Infect Dis, 2008, 46(6): 958-959.
[13] ZAHIRIFARD S, AMIRI MV, BAKHSHAYESH K, et al.The radiological spectrum of pulmonary multidrug-resistanttuberculosis: in HIV-Negative patients[J]. Iran J Radiol, 2003, 1(3-4): 161-166.
[14] CHUCHOTTAWORM C, THANACHARTWET V, SANGSAYUNH P, et al.Risk factors for multidrug-resistant tuberculosis among patients with pulmonary tuberculosis at the Central Chest Institute of Thailand[J]. PLoS One, 2015, 10(10): e0139986.
[15] 陈展峰, 陈海, 卓兆平, 等. 36 例耐多药肺结核的胸部 X 线影像特点观察[J]. 中国防痨杂志, 2011, 32(12): 837-838.
[16] LEIBOWITZ S, KENNEDY L, LESSOF MH.The tuberculin reaction in the pleural cavity and its suppression by antilymphocyte serum[J]. Brit J Exper Path, 1973, 54(2): 152.
[17] BAUMANN MH, NOLAN R, PETRINI M, et al.Pleural tuberculosis in the United States: incidence and drug resistance[J]. Chest, 2007, 131(4): 1125-1132.
[18] JEON K, CHOI WI, AN JS, et al.Paradoxical response in HIV-negative patients with pleural tuberculosis: a retrospective multicentre study[J]. Inter J Tuberc Lung Dis, 2012, 16(6): 846-851.
[19] CHA J, LEE HY, LEE KS, et al.Radiological findings of extensively drug-resistant pulmonary tuberculosis in non-AIDS adults: comparisons with findings of multidrug-resistant and drug-sensitive tuberculosis[J]. Korean J Radiol, 2009, 10(3): 207-216.
[20] FISHMAN JE, SAIS GJ, SCHWARTZ DS, et al.Radiographic findings and patterns in multidrug-resistant tuberculosis[J]. J Thorac Imaging, 1998, 13(1): 65-71.
[21] KIM HC, GOO JM, LEE HJ, et al.Multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in human immunodeficiency virus-negative patients: computed tomography features[J]. J Comput Assist Tomogr, 2004, 28(3): 366-371.
[22] CHUNG MJ, LEE KS, KOH WJ, et al.Drug-sensitive tuberculosis, multidrug-resistant tuberculosis, and nontuberculous mycobacterial pulmonary disease in nonAIDS adults: comparisons of thin-section CT findings[J]. Eur Radiol, 2006, 16(9): 1934-1941.
[23] JOSHI AR, MISHRA S, SANKHE AP, et al.HRCT Spectrum of Pulmonary Multidrug-Resistant Tuberculosis in HIV Negative Patients: A Study in Indian Population[J]. Interl J Sci Res, 2017, 6(4): 596-600.
[24] 李春华, 赵攀, 吕圣秀, 等. 127 例耐多药肺结核 CT 影像学改变与临床[J]. 重庆医学, 2014, 43(23): 3078-3080.
[25] 董莘, 陈红兵, 洪剑, 等. 耐多药继发性肺结核的薄层CT特征[J]. 中华临床医师杂志 (电子版), 2013, 7(21): 74-76.
[26] 毛旖川, 朱静芬, 李勇刚. 多重耐药肺炎克雷伯杆菌肺部感染临床与CT特征[J/CD]. 新发传染病电子杂志, 2018, 3(4): 206-209.
[27] YEOM JA, JEONG YJ, JEON D, et al.Imaging findings of primary multidrug-resistant tuberculosis: a comparison with findings of drug-sensitive tuberculosis[J]. J Comput Aassist Tomogr, 2009, 33(6): 956-960.
[28] KIM SH, MIN JH, LEE JY.Radiological findings of primary multidrug-resistant pulmonary tuberculosis in HIV-seronegative patients[J]. Hong Kong J Radiol, 2014, 17(1): 4-8.
[29] KIM W, LEE KS, KIM HS, et al.CT and microbiologic follow-up in primary multidrug-resistant pulmonary tuberculosis[J]. Acta Radiol, 2016, 57(2): 197-204.
[30] LI D, HE W, CHEN B, et al.Primary multidrug-resistant tuberculosis versus drug-sensitive tuberculosis in non-HIV-infected patients: Comparisons of CT findings[J]. PloS One, 2017, 12(6): e0176354.
[31] 刘扬, 龚圣兵, 陈严, 等. 中青年人初治耐多药肺结核的胸部 CT 征象分析[J]. 临床放射学杂志, 2016, 35(5): 719-722.
[32] LEE ES, PARK CM, GOO JM, et al.Computed tomography features of extensively drug-resistant pulmonary tuberculosis in non-HIV-infected patients[J]. J Comput Assist Tomogr, 2010, 34(4): 559-563.
[33] 孙华, 唐神结, 顾瑾, 等. 广泛耐药肺结核的胸部 CT 特点[J]. 中国防痨杂志, 2012, 33(2): 123-125.
[34] CHEON H.Comparison of CT findings of between MDR-TB and XDR-TB: A propensity score matching study[J]. Imaging Med, 2017, 9(5): 125-130.
[35] KAHKOUEE S, ESMI E, MOGHADAM A, et al.Multidrug resistant tuberculosis versus non-tuberculous mycobacterial infections: a CT-scan challenge[J]. Braz J Infect Dis, 2013, 17(2): 137-142.
[36] 余庭山, 沈晓兰, 龙显荣, 等. 非结核分枝杆菌肺病与耐多药肺结核的 CT 影像对比分析[J]. 天津医药, 2017, 45(6): 628-631.
[37] SONG Q, GUOQING Z, HONGBO J, et al.Imaging Features of Pulmonary CT in Type 2 Diabetic Patients with Multidrug-Resistant Tuberculosis[J]. Plos One, 2016, 11(3):e0152507.
[38] 王毅翔, CHUNG MJ, ALIAKSANDR S, 等. 与耐多药肺结核相关的放射学征象的文献分析[J/CD]. 新发传染病电子杂志, 2018, 3(4):244-253.
[39] CHEN RY, DODD LE, LEE M, et al. PET/CT and High Resolution CT as potential imaging biomarkers associated with treatment outcomes in MDR-TB[J]. Sci Trans Med, 2014, 6(265): 265ra166.
[40] CHOI JY, JHUN BW, HYUN SH, et al.18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Assessing Treatment Response of Pulmonary Multidrug-Resistant Tuberculosis[J]. J Clin Med, 2018, 7(12): 559.
[41] VORSTER M, SATHEKGE MM, BOMANJI J.Advances in imaging of tuberculosis: the role of 18F-FDG PET and PET/CT[J]. Cur Opin Pulm Med, 2014, 20(3): 287-293.
[42] GREENBERG SD, FRAGER D, SUSTER B, et al.Active pulmonary tuberculosis in patients with AIDS: spectrum of radiographic findings (including a normal appearance)[J]. Radiol, 1994, 193(1): 115-119.
[43] LESSNAU KD, GORLA M, TALAVERA W.Radiographic findings in HIV-positive patients with sensitive and resistant tuberculosis[J]. Chest, 1994, 106(3): 687-689.
[44] BLANCHARD JS.Molecular mechanisms of drug resistance in Mycobacterium tuberculosis[J]. Ann Rev Bioch, 1996, 65(1): 215-239.
[45] DAVID HL.Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis[J]. Appl Env Micr, 1970, 20(5): 810-814.
[46] LONG R.Drug-resistant tuberculosis[J]. CMAJ 2000, 163(7): 425-428.
[47] GENG E, KREISWIRTH B, BURZYNSKI J, et al.Clinical and radiographic correlates of primary and reactivation tuberculosis: a molecular epidemiology study[J]. Jama, 2005, 293(22): 2740-2745.
[48] GREENBERG SD, FRAGER D, SUSTER B, et al.Active pulmonary tuberculosis in patients with AIDS: spectrum of radiographic findings (including a normal appearance)[J]. Radio, 1994, 193(1): 115-119.
[49] FITZGERALD JM, GRZYBOWSKI S, ALLEN EA.The impact of human immunodeficiency virus infection on tuberculosis and its control[J]. Chest, 1991, 100(1): 191-200.
[50] NUNES EA, DE CEM, COELHO E, et al.Patterns of anti-tuberculosis drug resistance among HIV-infected patients in Maputo, Mozambique, 2002-2003[J]. Int J Tuberc Lung Dis, 2005, 9(5): 494-500.
[51] RAJASEKARAN S, VALLINAYAGI V, JEYAGANESH D.Unilateral lung destruction: a computed tomographic evaluation[J]. Ind J Tuberc, 1999, 46(1): 183-188.
[52] MIOTTO R, WANG F, WANG S, et al.Deep learning for healthcare: review, opportunities and challenges[J]. Brief Bioinform, 2018, 19(6): 1236-1246.
[53] GAO XW, QIAN Y.Prediction of multidrug-resistant TB from CT pulmonary images based on deep learning techniques[J]. Mol Pharm, 2017, 15(10): 4326-4335.